New hope for nigerian women with aggressive breast cancer
NCT ID NCT06348134
Summary
This study is testing a targeted cancer treatment approach for Nigerian women with HER2-positive breast cancer. Participants receive a combination of targeted drugs and chemotherapy both before and after surgery. The research aims to see how effective and safe this treatment is for controlling the cancer and improving outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lagos State University Teaching Hospital
RECRUITINGIkeja, Lagos, 100271, Nigeria
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-••••
-
Lagos University Teaching Hospital
RECRUITINGYaba, Lagos, 100254, Nigeria
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-••••
Contact
-
Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC)
RECRUITINGIle-Ife, Osun State, 220005, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Ibadan Hospital
RECRUITINGIbadan, Oyo State, 200285, Nigeria
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.